Lyang-ja Lee
KENTO Innovation Park NK
Settsu, Japan
Settsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
Journal: Journal of Alzheimer's disease : JAD
Published: June 07, 2024
A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
Journal: Journal of Alzheimer's disease : JAD
Published: November 28, 2019
New Biomarkers for Prediction of Disseminated Intravascular Coagulation in Patients With Sepsis.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: October 12, 2018
Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP®-MS analysis.
Journal: Journal of gastroenterology
Published: January 10, 2018
Cysteinylated transthyretin as a discriminator of cardiovascular risk in patients with diabetes mellitus.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: February 09, 2017
Potential Biomarker Peptides Associated with Acute Alcohol-Induced Reduction of Blood Pressure.
Journal: PloS one
Published: August 13, 2015
Simple quantitation for potential serum disease biomarker peptides, primarily identified by a peptidomics approach in the serum with hypertensive disorders of pregnancy.
Journal: Annals of clinical biochemistry
Published: March 31, 2015
Clinical peptidomic analysis by a one-step direct transfer technology: its potential utility for monitoring of pathophysiological status in female reproductive system disorders.
Journal: The journal of obstetrics and gynaecology research
Published: March 14, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026